Harvard’s serial entrepreneur Timothy Springer has formally launched his latest venture with a $101m series A round backed by GV.
Seismic Therapeutic, a US-based immunotherapy discovery technology developer, formally launched on Wednesday with $101m in series A funding from investors including co-founder Timothy Springer, a professor at Harvard University’s Medical School.
Venture capital firm Lightspeed Venture Partners led the round, which also featured internet technology group Alphabet’s GV unit, Boxer Capital, Polaris Partners, Samsara BioCapital as well as Seismic’s other co-founders and management team.
Seismic has built a machine…
